Users Discontinuing Anti-Obesity Medications Gain Back Weight at a Quadrupled Rate Than Those on Conventional Diets

Fresh analysis indicates that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt conventional lifestyle plans.

Research printed in a prominent health publication shows that while overweight people can lose about a fifth of their body weight while using the jabs, the weight returns at an estimated rate of 0.8 kg per month once they quit.

"Users using such medications should be aware of the potential of fast rebound weight gain when the treatment is stopped," cautioned expert Dr. Susan Jebb.

That rate of recovery means a return to original weight in about a year and a half.

Comparing Treatments

The study, which reviewed 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with other pills.

The team emphasize that individuals who shed pounds through diet and exercise generally experience a slower weight regain—around 0.1 kg a month—once they finish.

Explaining the Rapid Rebound

Nutrition scientists propose the mechanism of the drugs is key to understanding the heightened regain.

These medications mimic a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 levels several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' leads to hunger is no longer kept in check, making overeating much more probable."

A Lifelong Issue?

Medical guidelines recommend the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, given the significant potential of relapse, the therapy might need to be ongoing.

This view is supported by drug manufacturers, who state that the results "emphasize the persistent nature of obesity," akin to managing conditions like diabetes.

Patient Accounts

Individuals who have discontinued the medication explain a powerful resurgence of appetite.

"It felt as if something that goes on and you're instantly extremely hungry," recalled a patient.

This difficulty is exacerbated if individuals have not adopted permanent lifestyle or habit changes during treatment.

Significant Use

Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest remaining high.

• Adoption is greater among women than males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

In conclusion, experts stress that while these medications are potent agents for shedding pounds, they are not a magic fix and lasting health benefits likely depends on integrated behavioural support.